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Abstract: Background: The global pandemic has affected the psychological health of the population,
including pregnant women. Due to the difficulty of offering conventional therapies to reduce
stress in this population, studies are needed to show the effect of online therapies. Therefore, the
objective was to test the effect of online cognitive behavioural therapy in pregnant women during
the pandemic on the main variables of stress and psychopathology. Methods: The sample consisted
of 16 pregnant women who participated in a weekly cognitive behavioural intervention for 8 weeks.
Prenatal concerns, general stress, stress vulnerability, resilience and psychopathology were assessed.
Results: The results show a reduction in prenatal concerns, perceived stress, stress vulnerability and
psychopathology, as well as an increase in resilience. Conclusions: Online cognitive behavioural
intervention may be effective in pregnant women, so it is important to conduct a randomised
controlled trial to certify these findings.
Keywords: cognitive behavioural therapy; pregnancy; resilience; stress; online therapy
1. Introduction
The appearance of an outbreak of a new pneumonia disease caused by coronavirus
(COVID-19) in December 2019 has led to drastic changes in the population’s way of life,
carrying new challenges to be faced, as well as changes in social relations and personal
liberties [1].
In this way, a population that has been particularly affected are pregnant women,
who have presented an increase in their stress levels, depression and/or anxiety during
pregnancy [2,3]. This increase can have serious consequences on maternal and infant
health, as years of studies have demonstrated the close relationship between stress and
the development of depression in pregnancy and postpartum depression, increased risk
of preeclampsia and hypertension, increased risk of miscarriage, need for instrumental
deliveries, low foetal weight and premature birth [4–6]. In addition to these negative
consequences, it was recently shown that women who have gave birth during the pandemic
also experienced a low satisfaction with their delivery, higher levels of stress during
childbirth and increased symptoms of postpartum depression [7]. For that reason, different
psychological interventions have emerged with the aim of reducing the levels of stress in
pregnant women, such as mindfulness-based programs (MBPs) [8,9], relaxation techniques
such as progressive muscle relaxation and guided imagery [10] and even sport-based
interventions such as yoga [11,12]. However, evidence-based medicine highlights cognitive
behavioural therapy (CBT) as a treatment to reduce a wide range of psychopathology and
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stress [13]. CBT aims to modify distorted cognitive thoughts and interpretations of reality
that lead to disturbing emotions and feelings [14,15]. CBT for stress coping has shown great
results in reducing stress in pregnant women [16], or in reducing anxiety or depression
levels [17]. Thus, promoting such interventions during pregnancy can help reduce the
negative effects of stress and improve maternal and infant health. Thus, promoting such
interventions during pregnancy can help reduce the negative effects of stress and improve
maternal and infant health.
The pandemic has been a major barrier to psychological treatments, as they must now
be carried out online in many cases. However, some studies highlight the applicability
of this type of treatment, since video calls also allow for face-to-face interaction [18]. In
addition, the patient’s self-efficacy may increase, as success is less likely to be attributed
solely to the work of the therapist [19].
Therefore, it is necessary to test the feasibility of CBT for stress management in
times of pandemic, conducted telematically, in order to verify whether a subsequent
randomised controlled trial is appropriate. Thus, the aim of this study was to test the effect
of online cognitive behavioural stress management therapy (o-CBT) in pregnant women,
applied during the COVID-19 pandemic, on the main variables of psychological stress
and psychopathology.
2. Materials and Methods
2.1. Participants
This study included a total of 16 pregnant women. The inclusion criteria were:
pregnant women with a good command of spoken and written Spanish and with an
internet connection to follow the sessions. Exclusion criteria included having suffered from
a psychological illness in the past year or at present, or suffering from a current medical
illness. Given that some research recommends 12 participants as a minimum for pilot
studies [20], and taking into account our study objectives, design and intervention, research
suggests that a sample size of 16 participants is reasonable [21,22].
All women who agreed to participate read an information sheet and gave their con-
sent through an online questionnaire platform. The protocol of this study was reviewed
and approved by the Biomedical Ethics Research Committee of the Junta de Andalucía
(internal code 0401-M1-17). Moreover, this study followed the guidelines of the Helsinki
Declaration (AMM, 2008) and the Good Clinical Practice Directive (Directive 2005/28/EC)
of the European Union.
2.2. Instruments
First of all, participants were asked to answer some questions regarding sociodemo-
graphic and obstetric information. After that, the following instruments were used for the
psychological evaluation of the participants:
- The Symptom Checklist-90-Revised (SCL-90-R) [23,24]. This is a 90-item scale with
5 points, ranging from 0 (never) to 4 (extremely). This instrument is used to evaluate
nine different measurements: somatization, obsession–compulsion, interpersonal
sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and psy-
choticism. There are also seven additional items on the scale distributed among
3 global indexes of distress: the GSI, which measures overall psychological distress;
the PSDI, which is used to calculate the intensity of symptoms; and Positive Symptom
Total, used to measure the number of self-reported symptoms. The scores are con-
verted to percentiles (0–100) according to the author’s instructions. Percentiles ≥ 75
represent clinical symptoms in any of the subscales of this instrument. The nine dimen-
sions show a reasonable reliability, with a Cronbach’s alpha for internal consistency
of 0.81.
- Pregnancy Distress Questionnaire (PDQ) [25,26]. This is a 12-item scale that measures
pregnancy-specific stress related to maternal concerns about pregnancy, such as med-
ical problems, labour and delivery, physical signs and symptoms, bodily changes
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and the baby’s health. A 5-point Likert-type scale is used to collect responses where
4 = very much and 0 = not at all. The Cronbach’s alpha reliability coefficient is 0.71.
- Perceived Stress Scale (PSS) [27,28]. The PSS collects data on people’s perceptions of
general stress over the previous month. It is made up of 14 elements that are rated
on a 5-point Likert scale. (0 = never, 1 = almost never, 2 = once in a while, 3 = often,
4 = very often). Scores range from 0 to 56 (higher scores represent higher levels of
stress). The Spanish Cronbach’s reliability alpha coefficient is 0.81.
- Stress Vulnerability Inventory (IVE) [29]. It consists of 22 items that assess a person’s
proclivity to be affected by perceived stress. It has a Yes/No answer format. Items
receiving an affirmative answer add 1 point. The range of scores on the scale is 0 to 22,
with higher scores corresponding to greater vulnerability to stress. The scale is highly
reliable, with a Cronbach’s alpha of 0.87.
- Connor Davidson Resilience Scale (CD-RISC) [30,31]. It reflects the ability to cope
with stressful situations such as changes, personal problems, illness, pressure, failure
and feelings of pain. The CD-RISC-10 consists of 10 items, and a Likert scale with
5 response options ranging from 0 (“almost never”) to 4 (“almost always”). It has a
Cronbach’s alpha reliability coefficient of 0.86.
2.3. Procedure
The participants were recruited through the dissemination in social networks of news
published in different newspapers and media for two weeks. These news items included
the contact information of a researcher from the team, so that interested pregnant women
could get in touch. All women who wished to participate read the study information
sheet and gave their consent through an online questionnaire platform. The objective was
to carry out two groups of 8–10 people each. Finally, 25 participants were interested in
participating, of which 6 did not meet the inclusion criteria. The remaining 19 took part in
two pilot groups to test the efficacy and feasibility of the online version of the treatment, of
which 16 completed the intervention.
Participants attended 8 consecutive weekly o-CBT sessions of 1.5 to 2 h duration with
two trained psychologists with a master’s degree of 900 h of training in psychological
treatment. o-CBT was performed through Google Meet. In addition, the psychologists had
conducted the same intervention on several occasions in face-to-face format prior to the pan-
demic. A Google Forms link was administered, through which participants completed the
pre-treatment assessment, composed of the previously described assessment instruments.
The intervention was adapted from a previous treatment program [32], whose effi-
cacy has been demonstrated in pregnant women [16]. The program consists of 8 sessions
with the following content: (1) psychoeducation: what stress is, its characteristics, how to
identify stressors, how to react to them and what are its effects; (2) deactivation strategies
(thematic imagination and diaphragmatic breathing); (3) cognitive restructuring: cognitive
distortions; (4) cognitive restructuring: irrational beliefs; (5) alternative ways to control
your thoughts: self-instructional training and time management; (6) training in social
skills: assertiveness, fundamental assertive rights, saying no and requesting a change of be-
haviour; (7) relationship between anger and stress: emotional self-control; and (8) optimism
and sense of humour summary.
Each intervention followed the same structure and the same guidelines to assume the
standardisation of the contents. At the beginning of the session, participants received an
email with the link to connect to the virtual session, the documents needed to work during
the session, the behavioural self-report and the tasks to work on at home that week related
to the topic of the session. In order to maximize the benefits of the online intervention,
it was recommended at the beginning of each session to activate the camera and to use
headphones and microphone. In addition, all participants were encouraged to participate
in the sessions with different actions, such as: talking about their experiences, expressing
difficulties about the tasks between sessions, role-playing, etc.
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At the conclusion of treatment, the evaluation instruments described above were
administered again.
2.4. Data Analysis
First, a descriptive and frequency analysis was carried out to check the distribution of
the sample in the main sociodemographic and obstetric history variables.
Secondly, the Shapiro–Wilk test was used to test the normality of the data. In the case
of the SCL-90-R scores, since they did not present a normal distribution, the Wilcoxon W
test was performed for two related samples (pre and post). The rest of the scores (EEP,
PDQ, IVE, CDRISC) met the assumption of normality and therefore a Student’s t test was
performed for two related samples (pre and post).
Finally, to calculate the effect size of the statistically significant changes of the para-
metric variables that were analysed with the Student’s t test, Cohen’s d was used (small
effect size > 0.20, medium effect size > 0.50 and large effect size > 0.80). The calculation
is based on Borenstein’s formulas [33] for calculating the effect size in a t-analysis for
dependent samples. In the case of non-parametric variables, the formula proposed by
Cohen [34] (r = Z/
√
N) was used, where [Z] is the absolute value of the Z score and [N] is
the total number of observations. This effect size comprises values from 0 to 1, for which
Cohen (1988) recommended the following interpretations: r > 0.10 small effect size, r > 0.30
medium effect size and r > 0.50 large effect size.
Analyses were performed using the Statistical Package for the Social Sciences 26.0 for
Windows (SPSS, Armonk, NY, USA).
3. Results
3.1. Sample Description
A total of 16 pregnant women took part in the pilot study, with a mean age of 36.63 years
(SD = 3.36) and who were between 6 and 31 weeks of pregnancy (M = 20.50 weeks gestation;
SD = 7.81). All of them were Spanish and were married or cohabiting with their partner
(n = 16; 100%). In addition, 87.5% (n = 14) had a university degree. The rest of the variables
can be consulted in Table 1.
3.2. Changes in Psychological Variables at the End of Therapy in Pregnant Women
First, Student’s t-analyses for dependent samples showed statistically significant
differences in: pregnancy-specific stress (t = 4.446; p ≤ 0.001) with a medium effect size
(d = 0.671); perceived stress (t = 3.243; p ≤ 0.005) with a high effect size (d = 0.909);
stress vulnerability (t = 3.982; p ≤ 0.001) with a low effect size (d = 0.348); and resilience
(t = −2.643; p ≤ 0.01) with a medium effect size (d = 0.608). As can be seen in Table 2, after
finalizing the treatment women showed decreased scores in these variables.
Regarding the non-parametric analyses performed for the scores in the different di-
mensions of the SCL-90-R, statistically significant differences were found in obsessions and
compulsions (Z = −2.556; p ≤ 0.01) with a high effect size (r = 0.638); anxiety (Z = −3.201;
p ≤ 0.01) with a high effect size (r = 0.80); phobic anxiety (Z = −2.003; p ≤ 0.05) with a
medium effect size (r = 0.501); psychoticism (Z = −2.202; p ≤ 0.05) with a medium effect
size (r = 0. 550); and in the general scales of global severity index (Z = −2.030; p ≤ 0.05),
positive symptoms (Z = −2.207; p ≤ 0.05) and positive distress index (Z = −2.336; p ≤ 0.05).
In addition, it should be noted that the study population showed clinical scores (greater
than 70) on the SCL-90-R subscales of obsessions and compulsions, depression, anxiety
and psychoticism prior to treatment. These data and the means for each measure can be
found in Table 2. As can be seen, after treatment, not only was there a decrease in the
psychopathological symptom scores in these women, but also in depression, anxiety and
psychoticism, in which they went from clinical scores to normal scores.
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Table 1. Sociodemographic variables and obstetric information of the sample.




Weeks of gestation T0 20.50 (7.81)
T1 28.50 (7.81)
Married/cohabiting Yes 16 (100%)
Nationality Spanish 16 (100%)
Education level




Part-time employment 1 (6.3%)
Full-time employment 13 (81.3%)
Obstetric information
Primiparous Yes 7 (43.8%)
No 9 (56.3%)
Pregnancy method Spontaneous 14 (87.5%)
Fertility treatment 2 (12.5%)
Wanted pregnancy Yes 14 (87.5%)
No 2 (12.5%)
Previous miscarriages 0 9 (56.3%)
1 6 (37.5%)
≥2 1 (6.3%)
Note: T0 = pre-intervention; T1 = post-intervention.
Table 2. Differences in psychological measures before and after therapy.
Measures T0 T1 t/Z p d/r
PDQ 19.88(7.15) 15.25(6.49) 4.446 0.001 ** 0.671
PSS 28.75(5.62) 22.69(7.43) 3.243 0.005 ** 0.909
IVE 9.69(5.49) 7.50(5.98) 3.982 0.001 ** 0.348
CD-RISC 21.19(5.35) 24.63(5.89) −2.643 0.018 * 0.608
SOM 61.19(29.02) 53.69(32.48) −1.616 0.106 0.403
OBS 86.88(13.20) 78.88(16.50) −2.556 0.011 * 0.638
SEN 67.75(30.13) 59.81(30.12) −1.207 0.227 0.301
DEP 76.31(22.52) 68.56(27.56) −1.310 0.190 0.327
ANS 78.75(18.36) 68.81(22.90) −3.201 0.001 ** 0.801
SCL-90-R HOS 62.63(28.32) 58.69(32.74) −0.772 0.440 0.192
FOB 67.56(31.09) 52.88(36.54) −2.003 0.045 * 0.501
PAR 55.00(41.50) 48.94(41.99) −0.840 0.401 0.209
PSI 79.94(20.47) 67.75(26.98) −2.202 0.028 * 0.550
IGS 79.94(19.23) 68.88(28.13) −2.030 0.042 * 0.507
SP 81.56(19.00) 73.19(24.59) −2.207 0.027 * 0.551
PSDI 63.69(20.33) 50.00(27.14) −2.336 0.019 * 0.584
Note: T0 = pre-intervention; T1 = post-intervention; * = p value≤ 0.05; ** = p value ≤ 0.01;
PDQ = Pregnancy Distress Questionnaire; PSS = Perceived Stress Scale; IVE = Stress Vulner-
ability Inventory; CD-RISC = Connor Davidson Resilience Scale; SCL-90-R = The Symptom
Checklist-90-Revised; SOM = somatizations; OBS = obsession and compulsion; SEN = inter-
personal sensitivity; DEP = depression; ANS = anxiety; HOS = hostility; FOB = phobic anxiety;
PAR = paranoid ideation; PSI = psychoticism; IGS = global severity index; SP = positive symp-
toms; PSDI = positive symptoms distress index.
4. Discussion
The aim of this study was to verify the effect of o-CBT on stress management in
pregnant women. In order to achieve it, a 2 month online intervention (eight sessions) was
implemented with a total of 16 women.
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Firstly, it was proven that women who completed the intervention had a significant
reduction in their stress levels, both in perceived stress and pregnancy-specific stress. The
main component of o-CBT is stress management; thus, the online version of the therapy
supports the results found by previous authors in a randomised controlled trial [16].
Additionally, this reduction could have direct repercussions on maternal and foetal health,
since pregnancy-specific stress has been considered as a powerful predictor of negative
outcomes [35].
Additionally, there was a reduction in the vulnerability to stress and an increase in
resilience scores. These results are highly relevant, taking into account that not only the
problematic factors, such as stress levels, reduce, but it goes one step forward, increasing
resilience, which could also carry improvements in coping mechanisms, self-esteem and
general wellbeing [36,37].
In addition, there was found to be a decrease in various psychopathological symptoms
in the women who participated in the therapy. On one hand, obsession and compulsion
levels and phobic anxiety decreased; these are characteristic symptoms related to the actual
pandemic situation. The need to maintain extreme hygiene to avoid contagion, or the
fear of vertical transmission of the virus to the foetus, could underlie the presence of this
symptomatology [38,39]. Reducing these levels is a matter of extreme importance, since
obsessions and phobias, maintained during pregnancy, can shunt into intense fears that
disable the pregnant woman, occasionally resulting in a phobia towards childbirth, which
in addition generates low satisfaction towards it, a higher chance of suffering a traumatic
childbirth and even the need to require an instrumentalised procedure [6,40,41].
Furthermore, anxiety is highly related to the stress suffered and the phobic anxiety
previously described. Around 8% of pregnant women report suffering symptoms of
anxiety [42], which are related to the development of severe psychopathological disorders
after childbirth, such as postpartum depression, a higher chance of a preterm birth and
internalizing problems on the offspring [4,43].
Finally, psychoticism symptoms also reduced after therapy. Other authors have stated
that this symptomatology increases in pregnant women, probably due to an evolutionary
aspect of pregnancy, where the mother considers external agents as a threat [44]. During
pandemics such as the one we are enduring, this symptomatology can increase, because
in order to avoid contagion there is an aversion to meet new people or maintain a social
life [45]. o-CBT offers the possibility of increasing social support without having to be in
direct contact with their peers, which could be related to the diminishment of this symptom.
Additionally, on average, the participants started the therapy in the second trimester and
finished in the first weeks of the third trimester, where the psychological state of pregnant
women typically worsens [4]. As it has been verified, o-CBT palliated this psychological
worsening in the sample, helping to improve the psychological health during the third
trimester of pregnancy.
Despite the promising findings reported, this study presents a limitation; since this is
an applicability study, and does not have a control group, the changes found cannot be
related exclusively to the therapy’s efficacy. Moreover, despite following previous research
recommendations for sample size [20–22], the sample size is quite small, which could affect
statistical power. Apart from that, it would be interesting to include working-class women
in the future study, to see how stress is reduced in this sample. Therefore, it is of great
relevance to continue research of the efficacy of o-CBT, implementing at least one control
group. It would also be interesting to include an additional control group centred on social
support, in order to guarantee that the changes found are due to the abilities acquired
through the therapy and not just the supportive environment where pregnant woman
share experiences with their peers.
Preliminary results show an unquestionable improvement in the psychological health
of women who participated in the therapy, which is in accordance with the results of a
face-to-face version [16]. It is important to raise the fact that as the pregnant women had
no psychological illnesses in our sample, this may be a step towards implementing this
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therapy as a health-promoting measure. Nowadays, these interventions are especially
necessary during pregnancy as a means to promote health, in order to avoid the loneliness
and abandonment that is produced by a situation such as the pandemic we are living in
and to provide the pregnant women with strategies that help them palliate the negative
psychological effects caused by the pandemic.
Author Contributions: Conceptualization, J.A.P.-G.; methodology, J.A.P.-G. and C.M.-N.; data cu-
ration, B.R.-G. and C.M.-N.; resources, M.I.P.-R.; writing—original draft preparation, J.A.P.-G. and
B.R.-G.; writing—review and editing, M.I.P.-R.; supervision, M.I.P.-R. All authors have read and
agreed to the published version of the manuscript.
Funding: This work was supported by the Frontier Project “A-CTS-229-UGR18” of the Ministry of
Economy, Knowledge, Business and University of the Junta de Andalucía, co-supported by funds
from the European Regional Development Fund (ERDF)—a way to build Europe. Additionally,
Mr. Jose Antonio Puertas-Gonzalez has been awarded with an individual research grant (Spanish
Ministry of Science, Innovation and Universities, FPU program, reference number 18/00617).
Institutional Review Board Statement: This study followed the guidelines of the Helsinki Declara-
tion (AMM, 2008) and the Good Clinical Practice Directive (Directive 2005/28/EC) of the European
Union. In addition, the protocol of this study has been reviewed and approved by the Biomedical
Ethics Research Committee of the Junta de Andalucía (internal code 0401-M1-17).
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: Data are available on request to the corresponding author.
Acknowledgments: We would like to thank all the people who are struggling with the virus, and
all the pregnant women who participated in the study. This study is part of the doctoral thesis of
Jose A. Puertas-Gonzalez.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Anderson, R.M.; Heesterbeek, H.; Klinkenberg, D.; Hollingsworth, T.D. How will country-based mitigation measures influence
the course of the COVID-19 epidemic? Lancet 2020, 395, 931–934. [CrossRef]
2. Romero-Gonzalez, B.; Puertas-Gonzalez, J.A.; Mariño-Narvaez, C.; Peralta-Ramirez, M.I. Variables del confinamiento por
COVID-19 predictoras de sintomatología ansiosa y depresiva en mujeres embarazadas. Med. Clin. 2020, 156, 172–176.
[CrossRef] [PubMed]
3. Puertas-Gonzalez, J.A.; Mariño-Narvaez, C.; Peralta-Ramirez, M.I.; Romero-Gonzalez, B. The psychological impact of the
COVID-19 pandemic on pregnant pswomen. Psychiatry Res. 2021, 301, 113978. [CrossRef] [PubMed]
4. Caparros-Gonzalez, R.A.; Romero-Gonzalez, B.; Strivens-Vilchez, H.; Gonzalez-Perez, R.; Martinez-Augustin, O.; Peralta-Ramirez, M.I.
Hair cortisol levels, psychological stress and psychopathological symptoms as predictors of postpartum depression. PLoS ONE
2017, 12, e0182817. [CrossRef]
5. Christian, L.M. Physiological reactivity to psychological stress in human pregnancy: Current knowledge and future directions.
Prog. Neurobiol. 2012, 99, 106–116. [CrossRef]
6. Romero-Gonzalez, B.; Caparros-Gonzalez, R.A.; Gonzalez-Perez, R.; Coca-Arco, S.; Peralta-Ramirez, M.I. Hair cortisol
levels, psychological stress and psychopathological symptoms prior to instrumental deliveries. Midwifery 2019, 77, 45–52.
[CrossRef] [PubMed]
7. Mariño-Narvaez, C.; Puertas-Gonzalez, J.A.; Romero-Gonzalez, B.; Peralta-Ramirez, M.I. Giving birth during the COVID-19 pan-
demic: The impact on birth satisfaction and postpartum depression. Int. J. Gynecol. Obstet. 2020, 153, 83–88. [CrossRef] [PubMed]
8. Pan, W.L.; Gau, M.L.; Lee, T.Y.; Jou, H.J.; Liu, C.Y.; Wen, T.K. Mindfulness-based programme on the psychological health of
pregnant women. Women Birth 2019, 32, e102–e109. [CrossRef]
9. Shi, Z.; MacBeth, A. The Effectiveness of Mindfulness-Based Interventions on Maternal Perinatal Mental Health Outcomes: A
Systematic Review. Mindfulness 2017, 8, 823–847. [CrossRef] [PubMed]
10. Nasiri, S.; Akbari, H.; Tagharrobi, L.; Tabatabaee, A.S. The effect of progressive muscle relaxation and guided imagery on stress,
anxiety, and depression of pregnant women referred to health centers. J. Educ. Health Promot. 2018, 7, 41. [CrossRef] [PubMed]
11. Chen, P.J.; Yang, L.; Chou, C.C.; Li, C.C.; Chang, Y.C.; Liaw, J.J. Effects of prenatal yoga on women’s stress and immune function
across pregnancy: A randomized controlled trial. Complement. Ther. Med. 2017, 31, 109–117. [CrossRef]
12. Kusaka, M.; Matsuzaki, M.; Shiraishi, M.; Haruna, M. Immediate stress reduction effects of yoga during pregnancy: One group
pre post test. Women Birth 2016, 29, e82–e88. [CrossRef] [PubMed]
Behav. Sci. 2021, 11, 100 8 of 9
13. Butler, A.C.; Chapman, J.E.; Forman, E.M.; Beck, A.T. The empirical status of cognitive-behavioral therapy: A review of
meta-analyses. Clin. Psychol. Rev. 2006, 26, 17–31. [CrossRef] [PubMed]
14. Beck, A.T.; Rush, A.J.; Shaw, B.F.; Emery, G. Cognitive Therapy of Depression; The Guilford Press: New York, NY, USA, 1979.
15. Ellis, A.; Bernad, M. Reason and Emotion in Psychotherapy: Revised and Updated; Birch Lane: New York, NY, USA, 1994.
16. Romero-Gonzalez, B.; Puertas-Gonzalez, J.A.; Strivens-Vilchez, H.; Gonzalez-Perez, R.; Peralta-Ramirez, M.I. Effects of cognitive-
behavioural therapy for stress management on stress and hair cortisol levels in pregnant women: A randomised controlled trial.
J. Psychosom. Res. 2020, 135, 110162. [CrossRef] [PubMed]
17. Karamoozian, M.; Bahonar, S.; Askarizadeh, G. Impact of Prenatal Cognitive-Behavioral Stress Management Intervention on
Maternal Anxiety and Depression and Newborns’ Apgar Scores. Iran. J. Neonatol. 2015, 6, 14–23.
18. Murphy, R.; Calugi, S.; Cooper, Z. Challenges and opportunities for enhanced cognitive behaviour therapy (CBT-E) in light of
COVID-19. Cogn. Behav. Therapist 2021, 13, e14. [CrossRef]
19. Rivera, J.; Comeche, M.I.; Vallejo, M.A.; Vallejo-slocker, L. Internet versus face-to-face group cognitive-behavioral therapy for fi
bromyalgia: A randomized control trial. J. Psychiatr. Res. 2015, 68, 106–113. [CrossRef]
20. Julious, S.A. Sample size of 12 per group rule of thumb for a pilot study. Pharm. Stat. 2005, 4, 287–291. [CrossRef]
21. Billingham, S.A.; Whitehead, A.L.; Julious, S.A. An audit of sample sizes for pilot and feasibility trials being undertaken in the
United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med. Res. Methodol. 2013, 13, 104.
[CrossRef] [PubMed]
22. Bowen, D.J.; Kreuter, M.; Spring, B.; Cofta-Woerpel, L.; Linnan, L.; Weiner, D.; Bakken, S.; Kaplan, C.P.; Squiers, L.;
Fabrizio, C.; et al. How We Design Feasibility Studies. Am. J. Prev. Med. 2009, 36, 452–457. [CrossRef] [PubMed]
23. Caparrós Caparrós, B.; Villar, E.; Juan Ferrer, J.; Viñas Poch, F. Symptom Check-List-90-R: Fiabilidad, datos normativos y
estructura factorial en estudiantes universitarios. Int. J. Clin. Health Psychol. 2007, 7, 781–794.
24. Derogatis, L.R. Symptom Checklist-90-R (SCL-90-R): Administration, Scoring and Procedures Manual, 3rd ed.; NCS Pearson: Bloom-
ington, MN, USA, 1994.
25. Caparros-Gonzalez, R.A.; Perra, O.; Alderdice, F.; Lynn, F.; Lobel, M.; García-García, I. Psychometric validation of the Prenatal
Distress Questionnaire (PDQ) in pregnant women in Spain. Women Health 2019, 59, 937–952. [CrossRef] [PubMed]
26. Yali, A.M.; Lobel, M. Stress-resistance resources and coping in pregnancy. Anxiety Stress Coping 2002, 15, 289–309. [CrossRef]
27. Cohen, S.; Kamarck, T.; Mermelstein, R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24, 385–396. [CrossRef]
28. Remor, E. Psychometric Properties of a European Spanish Version of the Perceived Stress Scale (PSS). Span. J. Psychol. 2006, 9,
86–93. [CrossRef] [PubMed]
29. Robles-Ortega, H.; Peralta-Ramírez, M.I.; Navarrete-Navarrete, N. Validación de la versión española del inventarío de vulnerabil-
idad al estrés de Beech, Burns y Scheffield. Av. Psicol. Salud 2006, 62, 251–258.
30. Connor, K.M.; Davidson, J.R.T. Development of a new Resilience scale: The Connor-Davidson Resilience scale (CD-RISC). Depress.
Anxiety 2003, 18, 76–82. [CrossRef]
31. García-León, M.Á.; González-Gómez, A.; Robles-Ortega, H.; Padilla, J.L.; Peralta-Ramírez, M.I. Psychometric properties of the
connor-davidson resilience scale (CD-RISC) in the Spanish population. Av. Psicol. Salud 2019, 35, 33–40. [CrossRef]
32. Robles-Ortega, H.; Peralta-Ramírez, M.I. Programa Para el Control del Estrés; Pirámide: Madrid, Spain, 2006.
33. Borenstein, M. Effect Sizes for Continuous Data. In The handbook of Research Synthesis and Meta-Analysis, 2nd ed.; Russell Sage
Foundation: New York, NY, USA, 2009.
34. Cohen, J. The Effect Size Index: D. In Statistical Power Analysis for the Behavioral Sciences; Routledge: New York, NY, USA, 1988.
35. Lobel, M.; Cannella, D.L.; Graham, J.E.; DeVincent, C.; Schneider, J.; Meyer, B. Pregnancy-specific stress, prenatal health behaviors,
and birth outcomes. Health Psychol. 2008, 27, 604–615. [CrossRef]
36. García-León, M.Á.; Caparrós-González, R.A.; Romero-González, B.; González-Perez, R.; Peralta-Ramírez, I. Resilience as a protec-
tive factor in pregnancy and puerperium: Its relationship with the psychological state, and with Hair Cortisol Concentrations.
Midwifery 2019, 75, 138–145. [CrossRef]
37. García-León, M.Á.; Pérez-Mármol, J.M.; Gonzalez-Pérez, R.; García-Ríos, M.C.; Peralta-Ramírez, M.I. Relationship between
resilience and stress: Perceived stress, stressful life events, HPA axis response during a stressful task and hair cortisol. Physiol.
Behav. 2019, 202, 87–93. [CrossRef]
38. Davide, P.; Andrea, P.; Martina, O.; Andrea, E.; Davide, D.; Mario, A. The impact of the COVID-19 pandemic on patients with
OCD: Effects of contamination symptoms and remission state before the quarantine in a preliminary naturalistic study. Psychiatry
Res. 2020, 291, 113213. [CrossRef] [PubMed]
39. Di Mascio, D.; Khalil, A.; Saccone, G.; Rizzo, G.; Buca, D.; Liberati, M. Outcome of coronavirus spectrum infections (SARS, MERS,
COVID-19) during pregnancy: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2020, 2, 100107. [CrossRef]
40. Dikmen-Yildiz, P.; Ayers, S.; Phillips, L. Depression, anxiety, PTSD and comorbidity in perinatal women in Turkey: A longitudinal
population-based study. Midwifery 2017, 55, 29–37. [CrossRef] [PubMed]
41. Ford, E.; Ayers, S. Stressful events and support during birth: The effect on anxiety, mood and perceived control. J. Anxiety Disord.
2009, 23, 260–268. [CrossRef] [PubMed]
42. Gariepy, A.M.; Lundsberg, L.S.; Miller, D.; Stanwood, N.L.; Yonkers, K.A. Are pregnancy planning and pregnancy timing
associated with maternal psychiatric illness, psychological distress and support during pregnancy? J. Affect. Disord. 2016, 205,
87–94. [CrossRef] [PubMed]
Behav. Sci. 2021, 11, 100 9 of 9
43. Field, T. Postnatal anxiety prevalence, predictors and effects on development: A narrative review. Infant. Behav. Dev. 2018, 51,
24–32. [CrossRef] [PubMed]
44. Romero-Gonzalez, B.; Caparros-Gonzalez, R.A.; Gonzalez-Perez, R.; Garcia-Leon, M.A.; Arco-Garcia, L.; Peralta-Ramirez, M.I. I
am pregnant. Am I different?: Psychopathology, psychological stress and hair cortisol levels among pregnant and non-pregnant
women. J. Psychiatr. Res. 2020, 131, 235–243. [CrossRef]
45. Becerra-garcía, J.A.; Giménez, G.; Sánchez-Gutiérrez, T.; Barbeito, S.; Calvo, A. Síntomas psicopatológicos durante la cuarentena
por COVID-19 en población general española: Un análisis preliminar en función de variables sociodemográficas y ambientales-
ocupacionales. Rev. Esp. Salud Publica 2020, 94, 1–11.
